As chronic kidney disease (CKD) becomes one of the fastest-growing global health challenges, placing increasing strain on patients, communities and healthcare systems, Swedish-born global renal care provider Diaverum, part of M42, a global health leader powered by AI, technology and genomics, today unveiled kidney.com, a new AI-powered health assistant. Designed to make trusted, personalized kidney health education more accessible for people, the platform launches today in the UAE, France, Germany, Portugal and the UK, with additional markets to follow.
With up to 90% of people unaware they have chronic kidney disease until it is significantly advanced, and many lacking the knowledge and resources necessary to slow its progression, kidney.com provides accessible, interactive and personalized education at no cost. With a conversational AI interface trained on trusted clinical sources, evidence-based content on chronic and acute kidney conditions and tailored learning experiences that adapt to each user’s needs, kidney.com aims to raise awareness to help tackle the growing condition. Studies show that well-informed patients are less likely to be hospitalized and to visit emergency departments, underscoring how education improves outcomes, reduces health system costs and helps address health inequities.
Additional features include voice control, product label interpretation via file upload, and multilingual support, with English, Arabic, French, German and Portuguese interfaces live, and additional languages coming soon.
Rafael Romanini, Chief Executive Officer, Diaverum, said: “At Diaverum, combining science with compassion for meaningful progress in renal care is at the core of our DNA. With kidney.com, we’re extending that philosophy into the digital world, using AI-powered education to make kidney health knowledge accessible, relevant and actionable for everyone, anywhere, 24/7. This initiative reflects our broader commitment to helping people live fulfilling lives, while supporting the sustainability of healthcare systems through education, prevention and innovation.
CKD is also among the costliest chronic diseases for healthcare systems: in Europe alone, annual costs are estimated at €140 billion.
Dimitris Moulavasilis, Group Chief Executive Officer, M42, said: “At M42, we are reimagining how technology can empower healthier lives. kidney.com harnesses the power of advanced, natural-language AI to confront the one of the world’s fastest-growing lifestyle-related conditions. By combining trusted clinical expertise with intelligent technology, kidney.com helps patients, caregivers and entire communities make informed health decisions. This is a prime example of how responsible AI can make care smarter, empowering people to better manage and, where possible, slow the progression of chronic kidney disease..
As healthcare moves beyond general-purpose AI, kidney.com reflects a broader shift toward specialized, condition-focused systems designed to support real-world care. For quality and relevant health information, kidney.com was developed in collaboration with more than 30 nephrologists, physicians and nurses spanning 13 countries and by completing over 14,000 chat interactions during the testing phase to ready the platform for real-world use. Ongoing clinical input is expected as kidney.com expands into additional markets. While not a medical device and not designed to diagnose or recommend treatment, kidney.com complements professional medical guidance, supports proactive self-management and has been developed in line with applicable privacy and data protection regulations across markets.
Prof. Rainer Woitas, Country Medical Director at Diaverum Germany, adds: "Education has always been a central pillar of good medicine. When people understand their condition, they take a more active role in their treatment and are better able to take steps on their own. We have consistently found that this improves treatment adherence, reduces complications, and directly contributes to better health outcomes.
kidney.com translates complex, evidence-based knowledge about kidney health—drawn from more than three decades of Diaverum’s experience and expertise—into personalized guidance. In doing so, kidney.com strengthens and complements the vital role of healthcare professionals."
The launch of kidney.com underpins Diaverum and M42’s shared commitment to build next-generation healthcare systems powered by AI, data and intelligence. It sets a new standard beyond general AI, with clinically specialized, human-centered systems transforming trusted knowledge into everyday understanding to empower individuals and support smarter, data-driven care.
